News

Innovative Life Science Conference Set for May 2025 in Israel

Innovative Life Science Conference Set for May 2025 in Israel

Biomed 2025: A Gathering of Innovation in Life Sciences

Prepare for an exciting future at Biomed 2025, the foremost Life Science and HealthTech conference, which is set to occur from May 20-22 at the prestigious David InterContinental Hotel. This annual event has established itself as a vital meeting point for health and technology leaders to explore new frontiers in the medical field.

Investment Opportunities on the Agenda

A highlight of the conference is the plenary session that will showcase a panel of industry leaders discussing the complexities of investment in healthcare. Titled The Investment Tango: VCs, Bankers, and the Dance of Deal-Making, this session promises to be enlightening for attendees interested in the financial aspects of health technology.

Panel of Experts

Attendees will have a chance to hear from a distinguished group of speakers, including:

  • Michael Margolis, Senior Managing Director at Oppenheimer & Co.
  • Michael Rice, Founding Partner at LifeSci Advisors
  • Nick Pachuda, MD, General Partner at Neovate Capital Partners
  • Mitchell Gold, MD, Venture Partner at Frazier Life Sciences
  • Jing Bao, MD, PhD, Partner at Shanghai HealthCare Capital
  • Craig Yeshion, MD, Managing Director at Perceptive Advisors

These industry veterans will share their insights on investment trends and the dynamic landscape of health tech.

Celebrating Innovation and Networking

Biomed 2025 will gather over 100 companies from the life sciences sector. This includes both emergent startups and well-established firms, showcasing innovative products and technologies. The conference is designed not just for presentations but also for networking opportunities, allowing participants to foster collaborations and partnerships.

Additional Plenary Speakers

The event will also feature notable figures such as:

  • Prof. Yitshak Kreiss, Director General at Sheba Medical Center
  • Philippe Gallone, Partner at Goldman Sachs
  • Prof. Yinon Ben Neriah, recipient of the Israel Prize
  • Dror Bin, Chief Executive Officer of the Israel Innovation Authority
  • Boaz Hirshberg, MD, Senior Vice President at Regeneron

Exploring the Future of Healthcare

The co-chairs of the event, Ruti Alon, Ora Dar, and Nissim Darvish, are committed to steering discussions that explore groundbreaking innovations transforming healthcare. They emphasize the gathering’s role in addressing urgent global healthcare challenges alongside advancements in direct patient care.

Ruti Alon pointed out, "Over the years, Biomed has evolved into a cornerstone for idea exchange and collaboration. This year’s unique challenges require us to adapt and rethink traditional methods within the medical landscape. The insights and connections made here will drive genuine change in the sector."

Engagement and Learning

This year's program is not only about addressing immediate concerns but also about navigating the crossroads of healthcare, technology, and societal impact. Participants can expect engaging discussions that delve into these intersections, emphasizing collaborative efforts that shape future health strategies.

Registration Details

Are you eager to participate in the Biomed 2025 conference? Registration details are available on the event's official website. It's a tremendous opportunity to immerse oneself in an environment rich with collaboration and innovation.

Frequently Asked Questions

What is Biomed 2025?

Biomed 2025 is an international Life Science and HealthTech conference focused on showcasing innovations and facilitating networking among industry leaders.

Where will the conference be held?

The event will take place at the David InterContinental Hotel, known for its excellent facilities.

Who are the key speakers at the event?

The conference will feature prominent figures from the healthcare sector, including investment bankers and CEOs from leading companies in the field.

What topics will be covered?

The agenda includes discussions on investment, innovation, and the future of healthcare as influenced by technology and global changes.

How can I register for the conference?

Registration details can be found on the Biomed conference website, where attendees can sign up for all scheduled sessions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

NCPDP CEO Lee Ann Stember Retires After 46-Year Legacy

Updated Category News Views 68

A Remarkable Milestone in Healthcare Leadership It's not every day someone hangs up their boots after 46 years of relentlessly steering the ship, especially in the tumultuous seas of healthcare. Come June 1, 2027, Lee Ann Stember plans to do just that as she retires as President & CEO of the National Council for Prescription Drug Programs (NCPDP). Her tenure is marked by...

Continue Reading
CGI Shines with Strong Q4, Announces Dividend Hike

Updated Category News Views 57

CGI Records Impressive Fourth Quarter Growth Well, CGI's got reason to strut its stuff this time around. Clocked in with a fourth-quarter revenue of $4.15 billion - that's a nice 3.3% bump up year-over-year, if you leave the currency noise out of it, it's about 2.5%. The real kicker? Net earnings shot up 20.8%. In a world where everyone’s fighting over scraps, these...

Continue Reading
Graphy's EU-MDR Milestone: A New Era for Dental 3D Printing

Updated Category News Views 103

TeraHarz Material Certification: A Step Forward The medical device world has its own Everest, and for Graphy Inc., scaling it means navigating the EU's toughened Medical Device Regulation. They’ve done just that for five of their TeraHarz materials, gearing up to snatch those shiny CE-MDR certificates soon. For anyone keeping tabs on the dental market, that’s a big...

Continue Reading
Yeastar 2026 Summit: AI, Growth, and Global Vision

Updated Category News Views 114

Reflecting on Two Decades of Innovation Yeastar's 20th anniversary summit in Xiamen was no ordinary gathering. It wasn't just about handshakes and business cards. Nope, it was a celebration intertwined with a deeper vision of growth and influence in the UCaaS space that Yeastar has carved out for itself over the years. Here's a company that's been plotting its course for...

Continue Reading
Gulliver Prep's New STEAM Complex to Transform Miami

Updated Category News Views 18

Gulliver Prep Leads the Charge in Education Innovation Gulliver Preparatory School just dropped a bombshell in Miami—almost literally, with their shovels hitting the dirt for a new 95,000-square-foot STEAM complex. It's not some lip-service to educational buzzwords either. This project's part of 'The Next 100: The Centennial Campaign for Gulliver,' a mega drive to...

Continue Reading
Abbisko's PIMJETMI® Gains FDA Nod, Boosting TGCT Treatment

Updated Category News Views 174

PIMJETMI® Scores FDA Approval, Expanding Global Reach Well, here's something to chew on over your morning coffee—PIMJETMI® (pimicotinib) just snagged the U.S. FDA's blessing to treat tenosynovial giant cell tumor (TGCT), making it another notch on Abbisko Therapeutics' belt. This approval is a strategic home run for Abbisko and their pals at Merck KGaA, Darmstadt,...

Continue Reading
Jill De Forest Honored: A Journey Through Recruitment

Updated Category News Views 104

A Force in Recruitment: Jill De Forest There's a name that reverberates through the corridors of executive search and recruitment: Jill De Forest. Recognized by The Inner Circle as the Pinnacle Professional of The Year, De Forest has left a profound mark on the industry with her knack for matching exceptional talent to major brands. Trailblazing through Executive Search...

Continue Reading
Tokyo SME Support Boosts Profit Amid Rising Costs

Updated Category News Views 119

transcosmos Takes Center Stage in SME Support Here's a tale straight out of Tokyo's bustling business streets: transcosmos stepping up to bolster small and medium-sized enterprises (SMEs) amidst the storm of skyrocketing operating costs. Now, Tokyo's SMEs face the ugly truth—rising prices and the weight of relentless inflation. This isn't some abstract economic mumbo...

Continue Reading
Flyers Fundraiser Supports Mental Health Advocacy in NJ and PA

Updated Category News Views 58

Blockbusters on Ice, Support Beyond the Rink Here's a twist for hockey fans out there: snagging tickets to catch the Philadelphia Flyers might pack more punch off the ice than on it. Why? Because, for every ticket you grab through Digital Elements Group's special link, $5 is pumped straight into the veins of mental health advocacy in New Jersey and Pennsylvania. Pretty...

Continue Reading
Victoria Jackson's No Makeup Movement Gets a Revival

Updated Category News Views 19

The Dynamic Duo Returns In a world stuffed to the gills with beauty products, and not that I'm a daily makeup wearer myself, it's refreshing to see folks like Victoria Jackson trying to strip it all down. Jackson, partnering with her business savvy husband Bill Guthy, is set to take the reins of No Makeup Makeup®. Now, Guthy is a big player stepping out from his stomping...

Continue Reading

Top 5 Most Recently Viewed Articles

Sportradar's Strong Growth: First Quarter Financial Overview

Updated Category News Views 264

Sportradar's Performance in the First Quarter of 2025 Welcome to the exciting world of sports technology, where innovation meets thrill! Sportradar Group AG (NASDAQ: SRAD), a prominent global sports technology company, has recently shared its preliminary financial results for the first quarter ending March 31, 2025. With a commitment to enhancing the experiences of sports...

Continue Reading
System-on-Chip Market to Reach $205.97 Billion by 2029

Updated Category News Views 47

System-on-Chip Market Outlook The System-on-Chip (SoC) market is experiencing remarkable growth, driven by various factors that span several industries. With a current valuation of approximately USD 138.46 billion and expectations to surge to USD 205.97 billion by 2029, the trend represents a significant Compound Annual Growth Rate (CAGR) of about 8.3%. Key Drivers of...

Continue Reading
Why Investing in Pampa Energia (NYSE: PAM) Makes Sense Now

Updated Category News Views 206

Pampa Energia: A Prime Investment Opportunity Pampa Energia S.A. (NYSE: PAM) stands out in the energy sector, thanks to its strategic investments that enhance its asset quality and boost electricity generation capabilities. The company is focused on expanding its reach in electricity generation, transmission, and distribution, making it a compelling option for investors...

Continue Reading
XTI Aerospace Eyes Growth Amid Revenue Slip

Updated Category News Views 108

A Second Quarter Snapshot Ah, the world of aerospace—where soaring ambitions often face a reality check. XTI Aerospace, hitching a ride on the drone tech boom, found itself dealing with a mixed bag this past second quarter. Coming from the streets of Miami with its quarterly numbers, XTI's interim CEO Jeremy Schneiderman is banking on drones to lift their revenue skies....

Continue Reading
CARVYKTI® Shows Promising Long-Term Remission Rates in Myeloma

Updated Category News Views 256

Revolutionary Insights on CARVYKTI® for Myeloma Treatment Recent findings from the CARTITUDE-4 study shed light on the exciting potential of CARVYKTI® (ciltacabtagene autoleucel), offering new hope for patients battling relapsed or refractory multiple myeloma. The data indicate that a significant 80% of patients treated with this innovative therapy experienced no...

Continue Reading